Investor Relations Home

Spotlight Innovation Inc. (OTCQB: STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, we leverage our extensive relationships with leading scientists, academic institutions and other sources.

We provide value-added development capability to accelerate development progress. When scientifically significant benchmarks have been achieved, we will endeavor to partner with proven market leaders via sale, out-license or strategic alliance.

Request Additional Information
Contact us by clicking here.

Investor Relations Firm
IRTH Communications, LLC
401 Wilshire Blvd
12th Floor, #111
Santa Monica, CA 90401
866-976-IRTH (4784)
info@irthcommunications.com

STLT
0.450
+0.100 (28.57%)


COMPANY OVERVIEW


Spotlight Innovation
Company Overview February 2016

Click this link to view the PDF in your browser or right click and “Save As…” to download

Spotlight Innovation Investor/Company Overview


ANALYST COVERAGE


SeeThruEquity
Zack’s Small Cap Research